To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves sNDA for Sunovion's Aptiom

FDA approved an sNDA for Aptiom eslicarbazepine acetate (BIA 2-093, SEP-0002093) from the

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE